Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Types of companies using IDdb


 

IDdb is the leader in intelligence tools used by most of the key players in the field of drugs research and development.

It is a valuable part of their knowledge library, with instant access, easy to use search facilities, reliable information and time saving features.

FEATURES

Pharmaceutical and Biotechnology Companies
Over 90% of the world's largest pharmaceutical companies subscribe to IDdb.

User numbers within these companies continue to grow as IDdb is increasingly used as an enterprize-wide pharmaceutical intelligence tool. More and more small to medium-sized pharmaceutical and biotechnology companies are also subscribing.

Chemical Companies
This market continues to grow as chemical companies realize IDdb has all the tools needed to investigate, evaluate and approach new business partners in the pharmaceutical and biotechnology industries. The powerful sub-structure searching capabilities are just one such tool.

Contract Research Organizations
Many large CRO's use IDdb to research, find and analyze potential business partners. IDdb has the most extensive therapeutic patent and clinical trial information available in a single database.

Investment Analysts
With the vast investment potential in the pharmaceutical industry, analysts are utilizing IDdb on a daily basis. Structured sales forecast data from some of the world's top investment analysts, plus additional expert commentary puts the information into context and makes IDdb an indispensable tool for the investment analyst.

Medical Communication Companies
IDdb provides strategic and tactical support for Medical Communication Companies through comprehensive and up-to-date reports and pharmaceutical intelligence.


 


 

Additional Information

Further Resources

Subscribe

Support Center

Visit our Support Center - packed with support, reference and training information to help you use our products effectively.

 
Disclaimer | Terms of Use
Privacy Policy | Copyright